Robotics Cancer Surgeon- Dr. David Samadi

Our health is key in our day to day activities, and medical experts advice us to frequently visit the medical facilities for check-ups. Frequent medical check-ups help one to prevent an illness or even a condition and even treat a disease at an early stage. One of the diseases that has been a challenge to the world is cancer. Medical experts are now specializing in the prevention, and the treatment of cancer and one of the cancer experts are Dr. David Samadi.

Dr. David Samadi specializes in robotic surgery for surgical treatment of prostate cancer. Dr. Samadi goes beyond treating prostate cancer, he goes ahead to teach his patients on how to be cancer free and how to have a safe future. Dr. Samadi is currently a doctor at Lenox Hill Hospital, New York. David was born in Iran and he was raised in Persia. Together with his brother, they moved to Belgium due to the Iranian Revolution, and they began life without their parents. From an early age, Dr. Samadi knew he wanted to be a doctor and specialize in prostate cancer. After his High school graduation, he went on to further his education and graduate from Stony Brook School of Medicine, and later joined Montefiore Medical Center and Albert Einstein College of Medicine for his postgraduate.

Ever since Dr. David Samadi began his medical practice, David has achieved a lot one being able to successfully perform over 7000 surgeries. He has been able to treat about 90% of his patients through his new technology SMART which means Samadi Modified Advanced Robotic Treatment using the Dan Vinci system. Apart from his office where he meets and treats patients, Samadi also gives medical advice on other platforms including Sunday Housecall which he has done for more than five years. During an interview, Samadi was asked how he began his practice and what led him to deal with prostate cancer, and he said that he has always loved helping others and after his training as prostate cancer surgeon he saw the need to learn about robotics surgeon. He further said that through robotic he has been able to help men suffering from prostate cancer and they are now cancer free.

For the years he has been in the medical section, he has achieved a lot and he has also been recognized on several occasions for his achievements. Some of the awards he has received include being named New York Super Doctors in 2014, America’s Top Doctors for Cancer, Vitals Patients’ Choice Award, and Most Compassionate Doctors among others. Dr. David Samadi continues to do what he loves by treating men and assuring them of a great future.

Dr. David Samadi’s Facebook Page:

The Life, Work and Achievements of Dr. David Samadi

Dr. David Samadi is a licensed Urologist whose specialty is in the treatment and diagnosis of cancers related bladder, kidney, prostate and urologic diseases. He also an expert invasive remedies for prostate cancer as well as laparoscopic robotic and laparoscopic radical prostatectomy.

Dr. Samadi is from Iran’s Persian Jewish Community. After the Revolution in Iran, when David Samadhi was 15 years old, he and his brother were coerced to leave their home place and go to Belgium. A lot had changed in his life when he was separated from his parents and Heidi, their little sister. He and his brother Dan were compelled to look after themselves. Nevertheless, David and Dan proved to be resilient and determined, and they did their best to make their parents feel full of pride.

David Samadi went on with his studies to be able to attain his dream of being a doctor. When Dan and David reached America both their lives turned better, and they were more than pleased with their new environment. The initial six years in America were fruitful for David Samadi, and in 1990 he finished his primary years with honors at the Stony Brook School of Medicine. In 1994 he earned his Master’s Degree from the State University of New York, and he achieved his post-graduate Urology training at the Montefiore Medical Center.

Samadi finished his proctology training in 1996 at the Albert Einstein College of Medicine, and likewise in 2000 at Montefiore Medical Center. In the year 2001, Dt. Samadi concluded his oncology fellowship in proctology at the Memorial Sloan-Kettering Cancer Center. Under the guidance of Professor Claude Abbou, he completed his fellowship on robotic radical prostatectomy in 2002 at the Henri Mondo Hospital Creteil in France.

Dr. David Samadi is the Vice Chairman of the Urology Department and the Chief of Minimally Invasive Surgery and Robotics at the Mount Sinai School where he is also a member of the faculty.

In his dedication to being of utmost help to others, Dr. Samadi developed the SMART Technique (Samadi Advanced Robotic Technique), which is a modern way to remove a prostate that is cancerous. The SMART lessens surgical time by 2 hours and allows a 24 hours recovery period in the hospital; and also minimizes the damage to nerves and tissues while in surgery. Dr. Samadi already had 7,000 surgeries using the mentioned technique that was successful.

Aside from his professional medical career, Dr. David Samadi also hosts the Sunday Housecall broadcasted on Fox News Channel having worked for five years with the said network.

Contact Dr. David Samadi:

Cancer Treatment Centers of America’s Innovative Approach

The Cancer Treatment Centers of America Global, Inc., or CTCA, is an entire network of five hospitals located the U.S. cities of Atlanta, Philadelphia, Chicago, Tulsa and Phoenix. The CTCA have joined forces with WebMD to help provide up-to-date information for cancer patients to learn more about their treatment options, diagnoses, therapeutics, coping strategies and caregiver support.

The CTCA offer a welcoming experience and complete care for their cancer patients. Their dedicated team of experienced clinicians will help each patient fight the disease physically and mentally. They practice an integrative approach for the treatment of cancer that focuses on creating therapies to enhance the patient’s strength, stamina and their overall well-being. All of their medical centers have advanced technologies and options for combating cancer that include: radiation, chemotherapy, surgery and immunotherapy. CTCA also provide a wide range of clinical trials that are supported by nation’s top scientist and medical researchers.

Founded in 1988 by Richard J. Stephenson, CTCA hospitals have continued to offer tailored treatment plans to millions of patients living with the disease. Mr. Stephenson had introduced an eye-opening and comprehensive way for clinical professionals to progressively care for their cancer patients during their treatment process. The organization’s headquarters are currently based in Boca Raton, Florida. On April 20, 2015, CTCA had opened their first international office for patient concierge and general info, it is currently located in a neighborhood in Mexico City. CTCA still offer help to cancer patients located in various countries and allow them to receive care in their hospitals in the U.S.

The Journey to Success in ADC Therapy- Seattle Genetics’ Clay Siegall

Events that happen to us when we are young do a lot to shape our future. When Dr. Clay Siegall was a teenager, his father was diagnosed with cancer. He watched his father struggle so much with the sickness that when he finally passed away, he has already realized that he needed to do something about the Harshness of the cancer therapies used at the time. Clay attended college at the University of Maryland and attained a Bachelor of Science degree in Zoology. He then proceeded to the George Washington University and acquired his Ph.D. in genetics. After he graduated, he worked for some companies such as The National Cancer Institute and Bristol-Myers Squibb Pharmaceuticals.

Clay always knew that he wanted to establish his own company which would be a platform to advance his research in cancer therapies. He combined efforts with a friend, and together they founded Seattle Genetics in 1998. Clay says that he knew they needed a solid philosophy that the company would operate under. They decided that their primary focus would be helping their patients. They also wanted to emphasize intensive research and scientific innovation. The efforts the company had put in these three areas paid off handsomely when their first ADC drug, ADCETRIS, was approved for use by the FDA in 2011. The company has since marketed the drug in more than 65 countries, and they have plans to expand even further.

When asked whether Seattle Genetics has any plans of selling out, Clay says that he had held on to the company, and believed in it even when the funds were insufficient. He did both public and private fundraising for the future of the enterprise. Siegall says that now that they have made it to an internationally recognized brand, he is not willing to sell out. He added that the company’s primary goal was to help their patients, which had nothing to do with money, adding that in the absence of money, they have been able to give their best service to humanity. Clay is a real inspiration in the world of science and entrepreneurship.